Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease - Merli, G; Spiro, T E; Olsson, C G (Ann Intern Med, 2001)
, et al; Enoxaparin Clinical Trial Group.